Dr. Peter Can Wickwire, MD

Dr. Wickwire practices at John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas.

Dr. Wickwire's NPI, 1427410851, was assigned on March 24, 2016. Dr. Wickwire graduated from University of Illinois College of Medicine - Chicago in 2016. Dr. Wickwire holds Texas license T1604.

Dr. Wickwire's primary practice is John Peter Smith Hospital, at 1500 S Main St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 921-3431.

Dr. Wickwire's primary practice is John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas. The medical group on file is Acclaim Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wickwire practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Wickwire's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Wickwire is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Wickwire's licenses on file in 2 states: Texas and California.

Dmand AI lists larynx and vocal cord disease and swimmer's ear among the conditions Dr. Wickwire treats.

CMS data shows 38 Medicare services from Dr. Wickwire across 2 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $1,969 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Wickwire in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 44% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wickwire's median patient age at 56, with 56% women.

In 2024, Dr. Wickwire wrote 117 Medicare Part D claims for 56 patients. 95% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $537 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Wickwire for performance year 2024, reported as part of a group. Dr. Wickwire accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Wickwire, published from 2018 to 2022. Dr. Wickwire's most frequent co-authors are Debbie A. Aizenberg, MD, Peter Charles Belafsky, MD, PhD and Daniel John Cates, MD.

CMS Open Payments shows 25 general payments to Dr. Wickwire from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 93% of the total. Olympus America Inc. paid the most, $178.

Dr. Wickwire graduated from University of Illinois College of Medicine - Chicago in 2016.

Dr. Wickwire is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.